Peroxisome proliferator-activated receptors (PPARs), members of the nuclear hormone receptor superfamily of transcription factors, are key regulators in various pathophysiological processes related to energy metabolism including lipid, carbohydrate metabolism, and inflammation. At present, little information is on the effect of age and calorie restriction (CR) on PPARs. In the present study, we investigated how age and CR (60% of the ad libitum intake) modulate PPARs in kidneys obtained from Fischer 344 rats, ages 13 and 25 months. Results showed that nuclear protein, mRNA level, and DNA binding activity of PPARs decreased with age, while CR blunted the reduction. Our findings were verified in separate experiments in which rats were injected with lipopolysaccharide, with the result of increased susceptibility to inflammation. Based on these findings, we conclude that the altered expression of PPARs may be due to increased oxidative stress with age, and that CR prevents these decreases through its antioxidative action.
data indicate that the PPAR activity mediates, through oxidative stress-sensitive pathways, redox-responsive nuclear factor-jB (NF-jB), activator protein-1 (AP-1), and signal transducers and activators of transcription (STAT) (9) . These findings suggest an important role for PPARs in controlling the inflammatory process, which could lead to potential therapeutic approaches for age-related inflammatory diseases.
Aging is a complex and multifactorial process, molecularly characterized by progressive, deleterious alterations in various transcription factors. From the standpoint of cell signal transduction pathways, age-related functional alterations can be elicited from an organism's loss in the ability to maintain the cellular signal pathways, partly due to increased oxidative status during aging (10) .
Recent research provides ample evidence for most of the transduction factors involved in the cellular signaling activity being extremely sensitive to oxidative stress and the redox state of the cell (11) . The current oxidative stress hypothesis of aging offers mechanistic explanations for increased oxidative stress and redox imbalance during aging (12) . This hypothesis predicts that the age-related redox imbalance results from elevated oxidative status due to unregulated reactive species (RS) and an accompanying weakened, counter-acting, antioxidative defense force that causes a disruption in normal cellular functions. A recent report from this laboratory on the modulation of redoxsensitive transcription factors during aging highlighted the essential nature of the redox status in the regulation of transcription factors (10) .
Our recent proposal on the age-related inflammatory process presented evidence that the oxidative process of the inflammatory process may be a major link bridging normal aging and many age-related degenerative diseases (13, 14) . Molecular explorations revealed that redox-sensitive NF-jB regulated proinflammatory molecules such as tumor necrosis factor (TNFa and TNFb), interleukins (IL-1b, IL-2, and IL-6), chemokines (IL-8 and RANTES), adhesion molecules (ICAM-1, VCAM-1, and E-selectin), and that enzymes such as inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2) increased with age (13) .
Calorie restriction (CR), a potent experimental paradigm for the retardation of aging, has been shown to exhibit broad and effective antioxidative properties (12) . Recent research provides strong evidence that CR may exert diverse antiaging benefits by its ability to modulate age-related oxidative stress and by its antiinflammatory effect (14, 15) . Several studies reported that CR attenuates age-related increases of proinflammatory cytokines (IL-1b, IL-6, and TNF-a) in myocardial ischemia-reperfusion injury and other diseases (16) (17) (18) . Based on the data from these studies and others, the beneficial effects of CR can be viewed as an outcome of the proper maintenance of cellular signal transduction activities through the modulation of various redox-sensitive transcription factors. Supporting this notion, our laboratory recently reported that the binding activity of redox-sensitive transcription factors, AP-1, NF-jB, and HIF-1, which DNA-increased during the aging process, was effectively suppressed by CR (10) .
Much is known about the activation of PPARs via PPREs and various PPRE participations, but far less information exists for the mode of PPAR modulation during aging. Although, the aging research literature does show that the activity and metabolism of peroxisomes decline (19, 20) and that expression of PPARa is reduced during the aging process (21, 22) , to date, no data are reported on the molecular regulation of PPARc and PPARa by CR during the aging process.
In the present study, we attempted to document agerelated changes in the expression and activity of PPARa and PPARc and the extent of their modulation by CR in aged rat kidney. In addition, we present data on lipopolysaccharide (LPS)-induced inflammatory reaction to further characterize the modulation of PPARa and PPARc under acute inflammatory conditions.
EXPERIMENTAL PROCEDURES

Animals and LPS Treatment Procedure
Animal.-Rat maintenance procedures for specific pathogen-free (SPF) status and the dietary compositions for chow and CR regimens have been previously reported (23) . This study complies with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (Publication No. 85-23) and was approved by an Institutional Animal Care and Use Committee of the University of Texas Health Science Center at San Antonio.
Briefly, male SPF Fischer 344 rats were fed a diet of the following composition: 21% soybean protein, 15% sucrose, 43.65% dextrin, 10% corn oil, 0.15% a-methionine, 0.2% choline chloride, 5% salt mix, 2% vitamin mix, and 3% Solka-Floc. The ad libitum (AL)-fed group had free access to both food and water. The animals designated as CR were fed 60% of the food intake of their AL-fed littermates, beginning at 6 weeks of age. Rats at 16 and 25 months of age were killed by decapitation, and the kidneys were quickly removed and rinsed in ice-cold buffer (100 mM Tris, 1 mM EDTA, 0.2 mM phenylmethyl-sulfonylfluoride [PMSF], 1 lM pepstatin, 2 lM leupeptin, 80 mg/L trypsin inhibitor, 20 mM b-glycerophosphate, 20 mM NaF, 2 mM sodium orthovanadate [pH 7.4]). Tissues were immediately frozen in liquid nitrogen and stored at À808C.
LPS treatment.-SPF male Fischer 344 rats at 13 and 31 months of age were separated into young (n ¼ 6) and old (n ¼ 6) groups, respectively. To investigate the effects of inflammation on the aging process, two additional groups were used for the injection of bacterial LPS. LPS was injected intraperitoneally with 5 mg/kg body weight doses in young (n ¼ 6) and old (n ¼ 6) rats. After 5 hours, rats were killed by decapitation and the kidneys quickly removed. The tissue was immediately immersed in liquid nitrogen and stored at À808C (24).
Primers.-Primers for reverse transcriptase-polymerase chain reaction (RT-PCR) were synthesized by Bioneer (Daejeon, Korea) and had the following sequences (the expected sizes are given in parentheses). rat PPARc: sense, 59-GGTGTGATCTTAACTGTCGG-39; antisense, 59-CAT-GGACACCATACTTGAGC-39 (530 bp), rat PPARa: sense, 59-GATGACCTGGAAAGTCCCTT-39; antisense, 59-AGGTAGGCTTCGTGGATTCT-39 (595 bp) and rat GAPDH: sense, 59-GGGTGATGCTGGTGCTGAGTAT-GT-39; antisense 59-AAGAATGGGAGTTGCTGTTGAA-GTC-39 (617 bp).
Preparation of nuclear extracts.-All solutions, tubes, and centrifuges were maintained at 08À48C. For each nuclear extract preparation, three rat kidney tissues were pooled. The preparation of nuclear extracts was based on previous methods (25) . All buffers contained 2 lg/ml of each protease inhibitor: aprotinin and leupeptin and 0.5 mM PMSF. Two grams of rat kidney harvested from young and old rats, were minced in phosphate-buffered saline. Minced tissue was incubated for two 15-minute intervals in relaxation buffer 1 (RBI; 100 mM KCl, 5 mM MgCl 2 , 5 mM EGTA, 5 mM sodium pyrophosphate, pH 6.8), followed by two 10-minute washes in RBII (50 mM KCl, 5 mM MgCl 2 , 1 mM EGTA, 1 mM sodium pyrophosphate, pH 6.8). The tissue was then washed with homogenization buffer A (0.3 M sucrose, 60 mM KCl, 0.15 mM spermine, 0.5 mM spermidine, 15 mM HEPES, pH 7.5, 0.5 mM EGTA, 2 mM EDTA, 10 mg/ml bovine serum albumin, 1 mM dithiothreitol [DTT]), followed by homogenization in fresh homogenization buffer A. Kidney tissue was disrupted with homogenizer. Kidney homogenates were then centrifuged at 1000 g for 10 minutes in a Beckman JA-25-50 rotor (Beckman, Fullerton, CA), and the pellets were solubilized in homogenization buffer B (0.3 M sucrose, 60 mM KCl, 0.15 mM spermine, 0.5 mM spermidine, 15 mM HEPES, pH 7.5, 0.1 mM EGTA, 0.1 mM EDTA, 10 mg/ml bovine serum albumin, 1 mM DTT) containing 0.5% (v/v) Triton X-100. The solubilized pellet was homogenized, followed by homogenization with a hand-held Teflon glass Dounce homogenizer. The nuclear pellet was solubilized in 10 ml of lysis buffer (10 mM HEPES, pH 7.5, 100 mM KCl, 3 mM MgCl 2 , 0.1 mM EDTA, 10% [w/v] glycerol). Nuclei were lysed by drop-wise addition of 3 M NH 4 SO 4 (pH 7.9) to a final concentration of 0.4 M, and the resulting extract was gently shaken for 30 minutes at 48C. The lysate was ultracentrifuged at 126,000 g for 1 hour, and the supernatant was collected. Solid NH 4 SO 4 (0.3 g/ml) was added slowly to the supernatant, and nuclear proteins were allowed to precipitate on ice for 30 minutes. Precipitated proteins were pelleted by ultracentrifugation at 126,000 g for 30 minutes and resuspended in 500 ll of dialysis buffer (25 mM HEPES, pH 7.6, 40 mM KCl, 0.1 mM EDTA, 10% [w/v] glycerol, 1 mM DTT). The muscle nuclear protein extract was dialyzed twice for 1 hour each time against dialysis buffer, and aliquots were quick frozen and stored at À808C in aliquots until the electrophoretic mobility shift assay (EMSA, see below) was done. Once thawed, nuclear protein extracts were not refrozen for use. The total protein concentration in samples was measured with a Sigma (St. Louis, MO) protein assay reagent kit containing bicinchoninic acid.
Electrophoretic mobility shift assay.-The EMSA method was used to characterize the binding activities of PPAR in nuclear extracts (26) . PPRE oligonucleotide was 59-CAAAACTAGGTCAAAGGTCA-39. Protein-DNA binding assays were performed with 10 lg of nuclear protein.
To minimize the effect of salt on binding, the concentration of salt was adjusted to the same level in all samples. Nonspecific binding was blocked by using 1 lg of poly(dIdC) Á poly(dI-dC). The binding medium contained 5% glycerol, 1 mM MgCl 2 , 50 mM NaCl, 0.5 mM EDTA, 2 mM DTT, 1.0% Nonidet P40 (NP40), and 10 mM Tris/HCl, pH 7.5. In each reaction, 20,000 cpm of a radio-labelled probe was included. Samples were incubated at room temperature for 20 minutes, and the nuclear protein-32 Plabelled oligonucleotide complex was separated from free 32 P-labelled oligonucleotide by electrophoresis through a 5% native polyacrylamide gel in a running buffer containing 50 mM Tris, pH 8.0, 45 mM borate, and 0.5 mM EDTA. After separation was achieved, the gel was vacuum-dried for autoradiography and was exposed to Fuji X-ray film (Seoul, Korea) for 1-2 days at À808C.
To determine the specificity of the nuclear protein binding, competitions were carried out under the same conditions using a 100-fold molar excess of the unlabeled PPRE oligonucleotide probe.
Western blotting.-Western blotting was carried out as described previously (27) . Homogenized samples were boiled for 5 minutes with a gel-loading buffer (0.125 M Tris-Cl, 4% SDS, 10% 2-mercaptoethanol, pH 6.8, 0.2% bromphenol blue) at a ratio of 1:1. Total protein-equivalent samples were separated by SDS-polyacrylamide gel as described by Laemmli (28) , and transferred to poly(vinylidene fluoride) membrane at 15 V for 1 hour in a semidry transfer system. The membrane was immediately placed into blocking buffer (5% nonfat milk) in TBS-T buffer (10 mM Tris, pH 7.5, 100 mM NaCl, and 0.1% Tween 20). The blot was allowed to block at room temperature for 1 hour. The membrane was incubated with anti-PPARc and anti-PPARa for 1 hour at 258C, followed by an antirabbit immunoglobin G (IgG)-horseradish peroxidase-conjugated antibody for 1 hour at 258C. Antibody labeling was detected using enhanced chemiluminescence per the manufacturer's instructions. Prestained protein markers were used for molecular weight determinations.
Isolation of RNA.-Total RNA was isolated using TRIZOL reagent (Gibco-BRL, Gaithersburg, MD), as per the manufacturer's instructions. Briefly, tissue samples were homogenized in the presence of Trizol (2 ml per 100 mg tissue) with several strokes in a tissue homogenizer. Aliquots of 0.2 ml chloroform per 1 ml homogenate were added. The samples were shaken vigorously for 15 seconds, and kept in ice for 5 minutes. The suspension was centrifuged at 12,000 g for 15 minutes at 48C. The aqueous phase was transferred to a fresh tube, to which an equal volume of isopropanol was added, and the samples were kept at 48C for 15 minutes. Samples were again centrifuged at 12,000 g for 15 minutes at 48C. The supernatant was removed and the RNA pellet was washed once with 75% ethanol by vortexing and subsequently centrifuged at 7500 g for 8 minutes at 48C. The pellet was dried for 10-15 minutes. The RNA pellet was dissolved in diethylpyrocarbonate (DEPC)-treated water.
Assay of RT-PCR.-Two micrograms of total RNA were used to generate a cDNA template for RT-PCR. The first strand synthesis was performed using random hexamers (Promega, Madison, WI) and Superscript II reversetranscriptase (Invitrogen, Carlsbad, CA). The first-strand cDNA products were further diluted and used as the PCR template. The PCR reaction in a total volume of 25 ll, containing 0.25 units of Taq polymerase, 0.25 mM dNTPs, PCR buffer (PE Applied Biosystems, Foster City, CA), and 50 ng of the relevant oligonucleotide primers. Parallel amplifications (20, 23, 26 , and 29 cycles) of a given cDNA were used to determine the optimum number of cycles. For each gene under study, a readily detectable signal within the linear range was observed after 29 cycles. For the actual analysis, samples were heated for 5 minutes at 948C, and then 23 cycles were carried out, each consisting of 1 minute at 948C, 30 seconds at 558C, and 1 minute at 728C. This was followed by a final 10-minute extension at 728C. In this study, GAPDH was used as the expression control. PCR reaction products were separated on a 1.2% agarose gel and visualized under ultraviolet light after ethidium bromide staining.
Statistical analysis.-For Western blotting and RT-PCR, data from three independent experiments were collected. The statistical significance of the differences between the treatments (age and diet) was determined by the analysis of variance (ANOVA) method. One-factor ANOVA was conducted to analyze significant differences among all possible age and diet pairs. Differences among the mean value of individual groups were assessed by the Fischer's Protected Least Significant Difference (LSD) post hoc test. Values of p , .05 were considered statistically significant.
RESULTS
Effect of Age and CR on PPARa and PPARc mRNA Levels
To determine gene expression alterations in PPARa and PPARc during aging, the RT-PCR assay was carried out to measure the abundance of PPARs mRNAs in young (13 months) and old (25 months) AL and CR rats. As shown in Figure 1 , we observed a slight decrease in PPARc ( Figure  1A ) and PPARa ( Figure 1B ) levels in mRNA. Compared with young AL rats, old AL rats showed decreased PPARa and PPARc mRNA levels of 30% and 46%, respectively. However, old CR rats showed higher levels of both PPARa and PPARc than their AL counterparts.
Effect of Age and CR on Nuclear PPARa and PPARc Protein Levels
To verify the possibility that a reduction of PPARa and PPARc levels in mRNA causes a decline in PPARa and PPARc protein levels during the aging process, we examined nuclear protein levels by Western blot analysis using PPARa-and PPARc-specific antibody. The results in Figure 2 show that nuclear levels of PPARc ( Figure 2A ) decreased with age in AL rats (84% decrease) and that CR (26% decrease) ameliorated this change. Likewise, aging markedly decreased nuclear levels of PPARa ( Figure 2B ). Compared with young AL rats, we observed a 53% decrease in old AL rats; however, the decrease (23%) was deterred in old CR rats.
Changes in PPAR Binding Activity by Aging and CR
We performed EMSA on rat kidney PPAR-DNA binding to examine whether a change in renal PPARs expression affects PPAR-DNA binding to PPRE, which is in the PPAR-binding domain. Figure 3A shows the film from the EMSA of PPAR-DNA binding in the AL and CR rats. Using a PPRE oligonucleotide, PPAR-DNA binding activity was significantly lower in old (25 months) compared with young (13 months) rats in the AL groups. We found that PPAR-DNA binding activity decreased by 64% in the old AL groups compared with the young (Figure 3B ). However, old CR rats showed higher (19% decreased) activity levels Figure 1 . Effect of age and calorie restriction (CR) on peroxisome proliferator-activated receptor-a (PPARa) and PPARc mRNA levels. Reverse transcriptasepolymerase chain reaction (RT-PCR) analysis of renal PPARc (A) and PPARa (B) were performed from RNA isolated from ad libitum (AL)-fed and CR rats. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) primers were used in separate PCR reactions to control for the efficiency of cDNA synthesis in each sample. A representative result is presented from three experiments. Densitometric measurements showed age-related decreases of PPARc and PPARa expressions in rat kidneys (n ¼ 3 per group). Statistical significance: *p , .05; **p , .01 versus young AL rats; #p , .05; ##p , .01 CR versus the age-matched AL rats. compared with their age-matched AL group. These data clearly showed that PPAR activation declines with age and that CR attenuates this age-related decline.
PPARa and PPARc Expression Changes During Aging and LPS Challenge
To duplicate our findings and to further understand the association between alterations of PPARs and the inflammatory response during aging, groups of young and old rats were challenged with a potent inflammatory stimulus, LPS. First, we used RT-PCR to measure mRNA levels in LPS-treated young and old rats. The results shown in Figure 4 indicate decreased concentrations of PPARc ( Figure 4A ) and PPARa ( Figure 4B ) in old (31-month-old) rats compared with young (13-month-old) rats, not only in the control group but also in the LPS-treated group, particularly, the old LPS-treated rats, which showed the lowest amount of PPARs among all groups.
Effect of Age and LPS-Induced Inflammation on Nuclear PPARc Protein Level
Previous studies report a decrease in PPARa with age and inflammatory stimuli in various tissues (21, 22, 29) . In this study, we investigated alterations of PPARc with age. To determine whether aging and LPS-induced inflammation influence PPARc expression, we performed Western blot analysis using a PPARc-specific antibody. We observed the level of nuclear PPARc protein to decrease with age and to be altered after LPS treatment ( Figure 4C ). When comparing old and young rats in the control group, we found that the nuclear PPARc protein level was significantly reduced (49%) in old rats compared with young rats. However, in LPS-treated groups, old rats showed an even greater reduction of nuclear PPARc level compared with LPS-treated young rats. The old LPS-treated rats expressed the lowest amount of nuclear PPARc proteins among all groups.
DNA Binding Activity of PPRE During Aging and LPS
To investigate the binding of PPAR to the PPRE consensus sequence during aging and inflammation, we used EMSA with nuclear extracts prepared from aged rat kidney to confirm PPAR DNA binding activity. EMSA data ( Figure 5) showed that the PPAR binding activity decreased in old rats compared with young rats. Moreover, this agerelated down-regulation was further decreased by the LPS challenge, indicating an increased susceptibility to inflammatory stimuli with age. This result corresponded with the decreases in nuclear PPARs and gene expression.
DISCUSSION
In a previous study, our group showed that age-related inflammation and oxidative stress enhanced various mRNA Figure 2 . Effect of age and calorie restriction (CR) on peroxisome proliferator-activated receptor-a (PPARa) and PPARc nuclear protein levels. Western blot analysis of renal nuclear PPARc (A) and PPARa (B) were performed from RNA isolated from ad libitum (AL)-fed and CR rats. A representative result is presented from three experiments. Densitometric measurements showed an age-related decrease of PPARc and PPARa expression in rat kidneys (n ¼ 3 per group). Statistical significance: **p , .01; ***p , .001 versus young AL rats; ##p , .01; ###p , .001 CR versus the age-matched AL rats. levels and protein expression in aged rat kidney (13) . Although many studies have shown a close association between redox-regulated transcription factors and aging and/ or inflammation (10), the effects of age on the alterations of PPARs are not well explored. Recent molecular data reveal that the susceptibility of aged animals to inflammatory insults may be due to an increased oxidative state and a disrupted redox state in these animals (13, 24) .
To better understand the alterations of PPARs during aging and their modulation at the molecular level, we assessed the extent of PPAR changes in mRNA and protein levels with age. In addition, we injected inflammatory LPS into young and old rats to examine a possibly altered PPAR status by prooxidative inflammation. Results revealed an age-related reduction of PPARa and PPARc in both mRNA and nuclear protein levels, which was detected in LPStreated rats. Activation of PPARs is indicated by DNAbinding to PPRE, the PPAR binding domain of the transcriptional regulating region. Our data provided the first direct evidence of altered PPARs with age and decreased PPAR DNA binding by inflammation. More interestingly, our results showed for the first time that the antioxidative effects of CR blunt age-induced decreases in PPARa and PPARc mRNA levels and protein expression. Data further revealed that CR improved the age-induced decrease in PPAR DNA binding activity to PPRE.
The down-regulation of PPARs by inflammation and oxidative stress was reported previously (22, 30) . Considering Figure 3 . Calorie restriction (CR) suppresses age-related decreases in peroxisome proliferator-activated receptor (PPAR) binding activity. A, The electrophoretic mobility shift assay (EMSA) method was used to compare nuclear PPAR binding activities in kidney nuclear protein from ad libitum (AL)-fed and CR rats. Lane 1: probe without nuclear protein sample (BL); Lane 2-5: kidney nuclear protein samples of AL and CR rats, ages 13 and 25 months, respectively. Lane 6: competition assay using 100-fold excess of unlabeled PPAR-response elements (PPRE) oligonucleotide. A representative result is presented from three experiments. B, Densitometric measurements showed age-related PPAR-DNA binding activity in rat kidneys (n ¼ 3 per group). Statistical significance: *p , .05; ***p , .001 versus young AL rats; #p , .05; ###p , .001 CR versus the age-matched AL rats. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) primers were used in separate PCR reactions to control for the efficiency of cDNA synthesis in each sample. C, Western blot analysis was performed to investigate renal nuclear PPARc protein levels in nuclear extracts from control and LPS-treated rats (n ¼ 6 per group). A representative result is presented from three experiments. Densitometric measurements showed age-related decrease of PPARc and PPARa expression in rat kidneys. The data shown are presented as young LPS untreated rat. Statistical significance: *p , .05; **p , .01; ***p , .001 versus young untreated rats; #p , .05; ##p , .01 LPS-treated rats versus the age-matched untreated rats.
! the close relation between oxidative stress and aging, the possible influence of aging on PPARs alterations can be expected. Among the altered expressions of inflammatory mediators, NF-jB and its related genes are of importance (13) . Chung and colleagues recently proposed the molecular inflammatory hypothesis of aging to emphasize the organism's susceptibility to incessant oxidative stresses and a disrupted redox balance (at submicroscopic and molecular levels), which gradually lead toward a proinflammatory stage during aging, which may develop into a full-blown pathologic condition during senescence (13) .
So far, there are just a few studies reporting the age effect on PPAR expression, which focused mainly on PPARa. For instance, Chao and colleagues (31) reported that aging had no effect on PPARa expression but that RXR changed in liver. However, these authors' findings conflict with those by Iemitsu and colleagues (21) and Carrera and colleagues (32) , who showed that age causes a marked reduction in the expression and activity of PPARa in old rat liver and heart. Our current data obtained from the kidney agree with what was found about old rat liver and heart.
Recently, a report (22) on an animal model of aging showed that the supplementation of a PPARa agonist, Wy 14,643, and dehydroepiandrosterone (DHEAS) corrected the age-induced up-regulation of NF-jB activity and the expression of several NF-jB-regulated genes. In addition, PPARa-deficient mice are shown to have higher oxidative stress at an earlier age than wild-type mice and have an exacerbated inflammatory response to LPS stimulation (33) . Taken together, these results give a strong implication to PPARa in the inflammatory process and oxidative stress.
PPARc, another member of the PPAR subfamily, may also be involved in modulating inflammation. PPARc activation through its agonists could interfere with the NF-jB and AP-1 pathways, and down-regulate NF-jB and AP-1-dependent genes, including COX-2, iNOS, and cytokines. However, the molecular mechanisms by which PPARc and PPARa regulate inflammatory response genes are not fully understood. A recent paper reports the activation of PPARainduced IjBa mRNA and protein expression and reduced NF-jB DNA binding activity, although it did not affect p65 nuclear translocation (34) . PPARc inhibits NF-jB-driven transcription by physically interacting with both p65 and p50 (35) .
Much of the accumulated evidence strongly implicates oxidative stress as a major factor contributing to the aging process and age-related diseases, such as neurodegenerative diseases, arteriosclerosis, diabetes, and inflammatory diseases (10) . Recent molecular studies show that the induction of oxidative stress is associated with the down-regulation of Figure 5 . Effects of age and lipopolysaccharide (LPS) on the PPAR-response elements (PPRE) DNA binding activity. A, The electrophoretic mobility shift assay (EMSA) method was used to compare nuclear peroxisome proliferator-activated receptor (PPAR) binding activities in kidney nuclear protein. Lane 1: probe without nuclear protein sample (BL); Lane 2-5: kidney nuclear protein samples of control (CTL) and LPS-treated (LPS) rats (n ¼ 6 per group). Lane 6: competition assay using 100-fold excess of unlabeled PPRE oligonucleotide. A representative result is presented from three experiments. B, Densitometric measurements showed age and LPSeffected PPAR-DNA binding activity in rat kidneys. The data shown are presented as young LPS untreated rat. Statistical significance: *p , .05; **p , .01 versus young untreated rats; #p , .05; ##p , .01 LPS-treated rats versus the age-matched untreated rats.
PPARs (36) (37) (38) and that activation of PPARa leads to a neuroprotective effect (39) . In addition, the activation of PPARc is shown to reduce oxidative stress and nitrative stress (40) .
Our findings on age-induced inflammation of PPARs were further tested in LPS-challenged rats. As expected, we observed that aged animals showed a much greater responsiveness to the LPS challenge than the young, implying an enhanced susceptibility and sensitivity to the inflammatory stimulus with age. Thus, the LPS challenge exacerbated the already existing oxidative stress (41, 42) , which may lead to further decreases in PPARs.
The possible inverse association between age-related changes in PPARs levels and oxidative stress was further supported by the antioxidative action of CR. Recent studies on CR provide clear evidence that CR likely exerts its diverse benefits through its antioxidative ability to suppress age-related oxidative stress while upholding the antioxidant defense system, including major ROS/RNS scavengers during aging (43) . In the present study, CR blunted the down-regulation of PPARs in aged rat kidneys, which could be explained by CR's antioxidative and antiinflammation action.
Conclusion
Our current data showed that the down-regulation of PPARs by the aging process might be correlated with agerelated oxidative stress, which was counteracted by the antioxidative action of CR. Based on these and other data, we propose that the prevention of the age-related decline in PPARs may be partly responsible for the suppression of the increased inflammatory process during aging. Molecular insights into the modulation of PPARs during aging and CR's ability to prevent decreases in PPARs will provide a better understanding of the role of PPARs in the aging process and the mechanisms underlying antiinflammatory action of CR.
